- Home
- KROS vs USNA Comparison
KROS vs USNA Comparison
Compare KROS & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- USNA
- Stock Information
- Founded
- KROS 2015
- USNA 1992
- Country
- KROS United States
- USNA United States
- Employees
- KROS N/A
- USNA N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- USNA Medicinal Chemicals and Botanical Products
- Sector
- KROS Health Care
- USNA Health Care
- Exchange
- KROS Nasdaq
- USNA Nasdaq
- Market Cap
- KROS 589.8M
- USNA 648.2M
- IPO Year
- KROS 2020
- USNA 1996
- Fundamental
- Price
- KROS $11.84
- USNA $34.31
- Analyst Decision
- KROS Buy
- USNA Hold
- Analyst Count
- KROS 11
- USNA 1
- Target Price
- KROS $45.33
- USNA $38.00
- AVG Volume (30 Days)
- KROS 2.1M
- USNA 103.2K
- Earning Date
- KROS 02-26-2025
- USNA 02-25-2025
- Dividend Yield
- KROS N/A
- USNA N/A
- EPS Growth
- KROS N/A
- USNA N/A
- EPS
- KROS N/A
- USNA 2.83
- Revenue
- KROS $651,000.00
- USNA $861,973,000.00
- Revenue This Year
- KROS $303.27
- USNA N/A
- Revenue Next Year
- KROS N/A
- USNA $11.73
- P/E Ratio
- KROS N/A
- USNA $12.13
- Revenue Growth
- KROS 8037.50
- USNA N/A
- 52 Week Low
- KROS $9.78
- USNA $31.44
- 52 Week High
- KROS $73.00
- USNA $52.75
- Technical
- Relative Strength Index (RSI)
- KROS 24.87
- USNA 43.54
- Support Level
- KROS $10.95
- USNA $33.61
- Resistance Level
- KROS $11.63
- USNA $34.59
- Average True Range (ATR)
- KROS 0.87
- USNA 0.94
- MACD
- KROS 1.31
- USNA 0.09
- Stochastic Oscillator
- KROS 30.60
- USNA 31.41
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.